Abacavir/Lamivudine Sandoz

Medicinal product

(Invented) name

Abacavir/Lamivudine Sandoz

Active substance (s)

Abakaviras/Lamivudinas

Strength

600 mg/300 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AR02, Lamivudine and abacavir

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2019-07-17

Date of renewal

Documents

0983_Abacavir_Lamivudine Sandoz_PZPL_2019-07-17.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

tabletėje yra	1 vnt.
Abakaviras	600 mg
Lamivudinas	300 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
102191	88292	1088292	lizdinė plokštelė	N30		Receptinis	LT/L/19/0983/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-10-20	Registruotas
2024-02-21	Išregistruotas
2019-07-17	Registruotas